TipRanks
Advertisement
Advertisement

CAMP Stock Latest News

Buy/Sell: Wall Street’s top 10 stock calls this week
The FlyBuy/Sell: Wall Street’s top 10 stock calls this week
12h ago
AVGO
CAMP
Camp4 Therapeutics initiated with a Strong Buy at Raymond James
PremiumThe Fly
Camp4 Therapeutics initiated with a Strong Buy at Raymond James
21h ago
CAMP
Camp4 Therapeutics initiated with a Buy at Needham
PremiumThe Fly
Camp4 Therapeutics initiated with a Buy at Needham
9d ago
CAMP
Camp4 Therapeutics initiated with an Outperform at Oppenheimer
PremiumThe Fly
Camp4 Therapeutics initiated with an Outperform at Oppenheimer
19d ago
CAMP
STOK
Buy Rating Reaffirmed on CAMP4 as ASCEND Trial Strategy and Pipeline Catalysts Support Long-Term Value; Price Target Maintained at $8
PremiumRatings
Buy Rating Reaffirmed on CAMP4 as ASCEND Trial Strategy and Pipeline Catalysts Support Long-Term Value; Price Target Maintained at $8
25d ago
CAMP
Camp4 Therapeutics price target lowered to $6 from $6.50 at Chardan
PremiumThe FlyCamp4 Therapeutics price target lowered to $6 from $6.50 at Chardan
25d ago
CAMP
CAMP4 Details ASCEND Trial Plans in SYNGAP1 Disorder
Premium
Company Announcements
CAMP4 Details ASCEND Trial Plans in SYNGAP1 Disorder
25d ago
8K
CAMP
Camp4 Therapeutics reports Q2 EPS (58c), consensus (21c)
Premium
The Fly
Camp4 Therapeutics reports Q2 EPS (58c), consensus (21c)
2M ago
CAMP
Camp4 Therapeutics price target raised to $15 from $12 at Piper Sandler
PremiumThe Fly
Camp4 Therapeutics price target raised to $15 from $12 at Piper Sandler
2M ago
CAMP
CAMP4 Analyst Day, Strong Cash Runway and SYNGAP1 Trial Progress Drive Upward Price-Target Revision to $8 with Buy Rating
PremiumRatings
CAMP4 Analyst Day, Strong Cash Runway and SYNGAP1 Trial Progress Drive Upward Price-Target Revision to $8 with Buy Rating
2M ago
CAMP
CAMP Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
CAMP Upcoming Earnings Report: What to Expect?
2M ago
CAMP
CAMP4 Therapeutics Secures $50 Million Private Financing
PremiumCompany Announcements
CAMP4 Therapeutics Secures $50 Million Private Financing
3M ago
8K
CAMP
CAMP4 gains Australian clearance, enabling CMP-002 trial and financing
PremiumCompany AnnouncementsCAMP4 gains Australian clearance, enabling CMP-002 trial and financing
3M ago
8K
CAMP
Camp4 Therapeutics receives Australia TGA clearance for CMP-002 trial
Premium
The Fly
Camp4 Therapeutics receives Australia TGA clearance for CMP-002 trial
3M ago
CAMP
X4 Pharmaceuticals appoints CAMP4 Therapeutics CFO Kelly Gold to board
Premium
The Fly
X4 Pharmaceuticals appoints CAMP4 Therapeutics CFO Kelly Gold to board
4M ago
CAMP
XFOR
Camp4 Therapeutics upgraded to Overweight from Neutral at JPMorgan
PremiumThe Fly
Camp4 Therapeutics upgraded to Overweight from Neutral at JPMorgan
4M ago
CAMP
CAMP4 Shareholders Approve Equity Plan Changes and Inducement Plan
PremiumCompany Announcements
CAMP4 Shareholders Approve Equity Plan Changes and Inducement Plan
4M ago
8K
CAMP
Camp4 Therapeutics initiated with a Buy at Chardan
PremiumThe Fly
Camp4 Therapeutics initiated with a Buy at Chardan
5M ago
CAMP
CAMP4 Highlights Preclinical Progress of SYNGAP1 Therapy
PremiumCompany Announcements
CAMP4 Highlights Preclinical Progress of SYNGAP1 Therapy
5M ago
8K
CAMP
Buy Rating Reaffirmed on CAMP4 as CMP-002 Advances Toward 2026 SYNGAP1 Trial and Strong Cash Runway Extends Into 2028
PremiumRatingsBuy Rating Reaffirmed on CAMP4 as CMP-002 Advances Toward 2026 SYNGAP1 Trial and Strong Cash Runway Extends Into 2028
6M ago
CAMP
Camp4 Therapeutics reports Q1 EPS (32c), consensus (21c)
Premium
The Fly
Camp4 Therapeutics reports Q1 EPS (32c), consensus (21c)
6M ago
CAMP
Camp4 Therapeutics initiated with a Buy at Rodman & Renshaw
Premium
The Fly
Camp4 Therapeutics initiated with a Buy at Rodman & Renshaw
6M ago
CAMP

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >